As the cradle of modern humanity, Africa is home to high levels of genetic diversity among its people, with significant implications for the safety and efficacy of many drugs.

Drug Safety Matters dives into the fascinating field of pharmacogenomics and the implications it has for tailored treatments and safer prescribing practices.

Better understanding of genetic variation – between individuals and subpopulations – can inform more refined choices of drugs and doses. A new ISoP group is set to drive progress.

Our genes contribute anything from 15 to 95% of how we react to medicines. Why is this the case, and when is genetic testing necessary to avoid the risk of potential side effects?